Forekomst av alkohol og andre rusmidler i blodprøver fra førere involvert i trafikkulykker
DOI:
https://doi.org/10.5324/nje.v6i1.332Sammendrag
SAMMENDRAG
Bilkjøring stiller store krav til førernes sansing, oppmerksomhet, informasjonsbearbeiding og evne til å
reagere. Førere som er under innflytelse av sentralnervøst aktive stoffer, vil derfor være en potensiell fare i
trafikken. I perioden 1.8–31.12. 1993 identifiserte Statens rettstoksikologiske institutt (SRI) 394 ulykkesførere
som politiet hadde rekvirert analyser av med hensyn på narkotiske stoff/sentralnervøst aktive medikamenter
(andre rusmidler) og/eller alkohol. Blodprøver fra disse førerne ble analysert med hensyn på alkohol og et
utvidet repertoar av andre rusmidler ved SRI. Da polititjenestemenn og medtrafikanter ofte ikke vil oppdage
påvirkning av andre rusmidler enn alkohol, dels pga. manglende alkohollukt, vil andre rusmidler som ulykkesårsak
være noe underrepresentert i dette materialet sammenliknet med alkohol. Hos 299 av ulykkesførerne
ble det påvist alkohol og/eller andre rusmidler. 44 førere hadde tatt inn både alkohol og andre rusmidler, mens
alkohol og andre rusmidler ble påvist alene i henholdsvis 204 og 51 saker. Totalt ble benzodiazepiner,
cannabis, opiater og amfetamin påvist i henholdsvis 54, 30, 17 og 16 saker. Av de 95 som hadde tatt inn andre
rusmidler, hadde 34 tatt inn mer enn ett rusmiddel (alkohol ikke medregnet) og i 72 av tilfellene ble analysefunnene
vurdert (AB og JM) til sannsynligvis å ha gitt sentralnervøs påvirkning. Risikoøkningen for trafikkulykke
ved nylig bruk av cannabisstoffer og diazepam i høydose ble estimert til å kunne tilsvare en blodalkoholkonsentrasjon
på 1-1,5 promille. Alkohol er det rusmiddel som oftest påvises hos ulykkesførere, men
forekomsten av benzodiazepiner, cannabis og amfetamin er såvidt høy blant ulykkesførere at disse stoffene
må anses å være et alvorlig trafikksikkerhetsproblem.
Bjørneboe A, Beylich K-M, Christophersen AS, Fosser S, Glad A, Mørland J.
Prevalence of alcohol and other intoxicants in blood samples from drivers involved in road traffic
accidents.
ENGLISH SUMMARY
Illegal and some legal drugs affect the central nervous system and drivers who use such drugs may represent a
hazard in the road traffic. The prevalence of such drugs among drivers involved in accidents depends on the
increase of the accident risk due to the drug and on the prevalence of the drugs among drivers on the road. In
this study we have examined blood samples from 394 drivers involved in road traffic accidents during the
period August–December 1993, to determine the prevalence of alcohol and drugs among drivers involved in
accidents. Most of the drivers enrolled in the study were suspected by the police of driving under the influence
of alcohol or drugs. The data are, however, probably somewhat biased, because drivers influenced by alcohol
or drugs will, if possible, avoid contact with the police. Furthermore, the police's ability to detect drivers
influenced by drugs is limited. Accordingly, the proportion of influenced drivers and especially drivers influenced
by drugs could be too low compared with the proportion among all drivers involved in traffic accidents.
In about 2/3 of the blood samples examined, alcohol was found either alone or together with other drugs,
and in 1/4 of the cases drugs were found either alone or together with alcohol. The most prevalent drugs were
benzodiazepines (13.7%), cannabis (7.5%), opiates (4.3%) and amphetamine (4.1%). In about 3/4 of the drug
positive cases the drug concentration was so high that it was considered likely or very likely that the driver
was influenced by the drug(s). The bias due to the police's inability to detect all drivers influenced by drugs
50
A. BJØRNEBOE OG MEDARBEIDERE
was estimated. After correction for this bias it was estimated that at least 2.7% of drivers involved in injury
accidents will have significant concentrations of drugs in the blood and at least 4.4% will have significant
blood alcohol concentrations.
Based on various sources of drug use in Norway we arrived at rough estimates of increase in risk of being
involved in road traffic accidents after different drug intakes. Driving a car the first few hours after cannabis
intake may increase the risk for an accident comparable to the risk involved when driving with a blood
alcohol concentration in the range 1.0 - 1.5 per mill. High doses of diazepam intake will most likely increase
the risk of an accident in the same order of magnitude.
We conclude that drunken drivers still constitute the main problem with regard to influenced driving on
Norwegian roads. Nevertheless, the relatively high frequency of drivers influenced by drugs among those
involved in accidents, demonstrates that these drivers are a serious safety problem.
Nor J Epidemiol 1996; 6 (1): 49-56.Downloads
Nedlastinger
Publisert
Hvordan referere
Utgave
Seksjon
Lisens
Norsk Epidemiologi licenses all content of the journal under a Creative Commons Attribution (CC-BY) licence. This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).